18F-FDG PET/CT for Monitoring Response of Merkel Cell Carcinoma to the Novel Programmed Cell Death Ligand 1 Inhibitor Avelumab

Naghmehossadat Eshghi*, Tamara F. Lundeen, Lea Mackinnon, Ryan Avery, Phillip H. Kuo

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Fingerprint

Dive into the research topics of '18F-FDG PET/CT for Monitoring Response of Merkel Cell Carcinoma to the Novel Programmed Cell Death Ligand 1 Inhibitor Avelumab'. Together they form a unique fingerprint.

Medicine & Life Sciences